171 related articles for article (PubMed ID: 20491625)
1. EGFR(s) in aging and carcinogenesis of the gastrointestinal tract.
Nautiyal J; Kanwar SS; Majumdar AP
Curr Protein Pept Sci; 2010 Sep; 11(6):436-50. PubMed ID: 20491625
[TBL] [Abstract][Full Text] [Related]
2. Regulation of gastrointestinal mucosal growth during aging.
Majumdar AP
J Physiol Pharmacol; 2003 Dec; 54 Suppl 4():143-54. PubMed ID: 15075456
[TBL] [Abstract][Full Text] [Related]
3. EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?
Kanwar SS; Nautiyal J; Majumdar AP
Curr Drug Targets; 2010 Jun; 11(6):682-98. PubMed ID: 20298154
[TBL] [Abstract][Full Text] [Related]
4. Role of ion channels in gastrointestinal cancer.
Anderson KJ; Cormier RT; Scott PM
World J Gastroenterol; 2019 Oct; 25(38):5732-5772. PubMed ID: 31636470
[TBL] [Abstract][Full Text] [Related]
5. The Role of Epidermal Growth Factor Receptor in the Management of Gastrointestinal Carcinomas: Present Status and Future Perspectives.
Mahmood MQ; Shukla SD; Dua K; Shastri MD
Curr Pharm Des; 2017; 23(16):2314-2320. PubMed ID: 28120720
[TBL] [Abstract][Full Text] [Related]
6. Anti-epidermal growth factor receptor-targeted therapy in upper gastrointestinal tract cancers: a meta-analysis.
Li A; Huang X; Song Y; Chen X; Sun J; Xu H; Wang Z
Growth Factors; 2015 Apr; 33(2):113-27. PubMed ID: 25697183
[TBL] [Abstract][Full Text] [Related]
7. Cathelicidin a potential therapeutic peptide for gastrointestinal inflammation and cancer.
Chow JY; Li ZJ; Wu WK; Cho CH
World J Gastroenterol; 2013 May; 19(18):2731-5. PubMed ID: 23687409
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapies in upper gastrointestinal malignancies.
Azzariti A; Silvestris N
Curr Med Chem; 2014; 21(8):947. PubMed ID: 23992326
[No Abstract] [Full Text] [Related]
9. The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy.
Matsunaga Y; Adachi Y; Sasaki Y; Koide H; Motoya M; Nosho K; Takagi H; Yamamoto H; Sasaki S; Arimura Y; Tokino T; Carbone DP; Imai K; Shinomura Y
Mol Carcinog; 2017 Feb; 56(2):515-526. PubMed ID: 27312358
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in gastrointestinal carcinoids.
Krishnamurthy S; Dayal Y
Am J Surg Pathol; 1997 Mar; 21(3):327-33. PubMed ID: 9060603
[TBL] [Abstract][Full Text] [Related]
11. MET as a potential target for the treatment of upper gastrointestinal cancers: characterization of novel c-Met inhibitors from bench to bedside.
Avan A; Maftouh M; Funel N; Ghayour-Mobarhan M; Boggi U; Peters GJ; Giovannetti E
Curr Med Chem; 2014; 21(8):975-89. PubMed ID: 23992325
[TBL] [Abstract][Full Text] [Related]
12. Targeted molecular ablation of cancer stem cells for curing gastrointestinal cancers.
Kim YS; Lee HJ; Park JM; Han YM; Kangwan N; Oh JY; Lee DY; Hahm KB
Expert Rev Gastroenterol Hepatol; 2017 Nov; 11(11):1059-1070. PubMed ID: 28707966
[TBL] [Abstract][Full Text] [Related]
13. Field cancerization in the GI tract.
Graham TA; McDonald SA; Wright NA
Future Oncol; 2011 Aug; 7(8):981-93. PubMed ID: 21823893
[TBL] [Abstract][Full Text] [Related]
14. Aquaporins: Their role in gastrointestinal malignancies.
Nagaraju GP; Basha R; Rajitha B; Alese OB; Alam A; Pattnaik S; El-Rayes B
Cancer Lett; 2016 Apr; 373(1):12-18. PubMed ID: 26780474
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options.
Kopp R; Rothbauer E; Ruge M; Arnholdt H; Spranger J; Muders M; Pfeiffer DG; Schildberg FW; Pfeiffer A
Recent Results Cancer Res; 2003; 162():115-32. PubMed ID: 12790326
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal malignancy and the microbiome.
Abreu MT; Peek RM
Gastroenterology; 2014 May; 146(6):1534-1546.e3. PubMed ID: 24406471
[TBL] [Abstract][Full Text] [Related]
17. The nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention.
Lyu Y; Xie F; Chen B; Shin WS; Chen W; He Y; Leung KT; Tse GMK; Yu J; To KF; Kang W
Oncogene; 2024 Jan; 43(2):77-91. PubMed ID: 38081962
[TBL] [Abstract][Full Text] [Related]
18. Role of progastrins and gastrins and their receptors in GI and pancreatic cancers: targets for treatment.
Rengifo-Cam W; Singh P
Curr Pharm Des; 2004; 10(19):2345-58. PubMed ID: 15279613
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
20. ADAM-Mediated Signalling Pathways in Gastrointestinal Cancer Formation.
Schumacher N; Rose-John S; Schmidt-Arras D
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
